EOLS Evolus, Inc.
Evolus, Inc. (EOLS) is expected to report earnings on February 3, 2027, after the market close. The consensus earnings estimate is $0.03 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +5.4% since its last earnings release on November 4, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Evolus, Inc.
Evolus is a performance beauty company with a customer-centric approach focused on delivering breakthrough products.
Sector
Healthcare
Industry
Medical Instruments/Supply
Held By 3 ETFs, by dollar flow
Charts powered in part by Lightweight Charts™ by TradingView.